Edition:
United Kingdom

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

47.98USD
19 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$47.98
Open
$47.54
Day's High
$48.18
Day's Low
$47.47
Volume
14,145
Avg. Vol
42,610
52-wk High
$68.91
52-wk Low
$17.07

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.94 December 20 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.20 0.50 0.00 0.00
Year Ending Dec-19 5 10.02 31.10 0.00 14.75
Earnings (per share)
Quarter Ending Sep-18 5 -0.94 -0.85 -1.01 -0.40
Quarter Ending Dec-18 5 -1.01 -0.83 -1.19 -0.48
Year Ending Dec-18 5 -3.72 -3.40 -3.95 -2.22
Year Ending Dec-19 5 -4.26 -2.26 -6.63 -2.11

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.48 0.48 0.00
Quarter Ending Dec-17 0.00 0.33 0.33 0.00
Quarter Ending Sep-17 5.75 7.81 2.06 35.86
Quarter Ending Jun-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.20 0.20 0.20 0.20 0.00
Year Ending Dec-19 10.02 10.02 10.02 10.02 14.75

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings